Dotmatics Hosts a Hugely Successful 2020 User Symposium
In October 2020, Dotmatics hosted a highly successful virtual User Symposium with 245 attendees from 24 countries, featuring live and on-demand sessions where Dotmatics scientists and industry experts from organizations like Debiopharm and Charles River Laboratories shared updates on development roadmaps, user experiences with software tools in areas such as Biologics and Small Molecule Discovery, and practical implementations like streamlined sample shipping workflows and global ELN rollouts, all aimed at fostering customer connection, knowledge exchange, and insight into upcoming product enhancements.
In October, Dotmatics hosted a successful User Symposium, providing customers with an opportunity to connect and share their experiences. The event was held virtually, attracting 245 attendees from 24 countries. Live sessions were recorded and made available on-demand until November 12th.
During the Symposium, Dotmatics scientists presented updates on development roadmaps across strategic areas, including Biologics Discovery, Small Molecule Discovery, Chemicals & Materials Innovation, and Lab Data Automation. Experts from organizations such as Debiopharm, Charles River Laboratories, Casma Therapeutics, Apollo Therapeutics, Firmenich S.A., and LabVoice shared their experiences using Dotmatics software to streamline scientific projects.
The annual User Symposium is a highlight of Dotmatics' events calendar, offering a platform for customers to exchange experiences in a supportive environment. Attendees shared positive feedback, noting the value of learning about upcoming products, hearing implementation stories from other users, and staying updated on Dotmatics developments.
The event opened with remarks from Dotmatics CEO Steve Gallagher. In addition to the live stream, educational sessions covered topics such as tips and tricks, new biologics tools, AI implementation, parallel chemistry workflows, and enhancements to Screening Ultra, BioBright, and Virtru. These sessions were also available on-demand.
Speakers from the scientific community highlighted their experiences with Dotmatics:
-
Jean Richardson, IT Scientist – Debiopharm: Discussed the complexities of sample shipping and management with CRO partners. Debiopharm implemented a streamlined shipping request workflow, allowing scientists to focus on scientific work rather than logistics.
-
Riannon Hambleton, Associate Director, Business Technology Partnership – Charles River Laboratories: Shared the experience of implementing an Electronic Lab Notebook (ELN) across global sites. The rollout emphasized cloud and SaaS capabilities, manageable project scope, early value delivery, and video-based training, receiving positive feedback from scientists.
-
Jarrod Medeiros, Director, Informatics and IT – Casma Therapeutics: Described deploying an ELN for biologists during the pandemic lockdown. Casma prioritized projects based on business needs, including bringing compound management in-house and integrating BioBright with Dotmatics systems for high content screening workflows.
-
Charlotte Lane, Project and Operations Director – Apollo Therapeutics: Shared three years of experience using Dotmatics. Apollo Therapeutics, a collaboration between academic institutions and pharmaceutical companies, manages a portfolio of 22 projects and works with over 15 CROs, emphasizing data security and integrity.
-
Marco Pacchiani, Vice President, Innovation Process & Knowledge Management – Firmenich S.A.: Outlined the Dotmatics implementation for knowledge generation within Firmenich's corporate research, replacing an outdated legacy system. Senior Scientist Céline Amoreira provided project details.
-
Dan DeAlmeida, Director of Product Management – LabVoice: Demonstrated integration between Dotmatics ELN and LabVoice's scientific vocabularies and voice transcription, enabling hands-free R&D data capture and improving workflow efficiency and data integrity.
The event concluded with informal networking in a virtual lobby and a "Technical Tent" hosted by Spatialchat, allowing attendees to join group discussions. While not the same as an in-person conference, the virtual format was well received.
Dotmatics expressed gratitude for the enthusiastic participation of attendees and speakers, which contributed to the event's success. Plans are already underway for next year's symposium, with hopes for a combined in-person and streamed event.
Related
A Decade of Data Sharing Change
Over the past decade, scientific R&D has shifted from viewing data sharing as problematic to a mandated practice driven by policies like the NIH’s 2023 Data Management and Sharing Policy, which emphasizes standardized data and metadata sharing to enhance reproducibility, collaboration, and innovation, while also necessitating technological advancements to manage the complexity of modern research data.
The Data Lifecycle: From Instrument Integration to Advanced Analysis
The article discusses how Dotmatics Luma™, a comprehensive scientific data platform, addresses the challenges faced by R&D teams in managing and integrating diverse, multimodal scientific data from instruments and various sources to streamline the entire data lifecycle—from ingestion and processing to advanced analysis—thereby enabling faster, AI-ready insights that accelerate innovation and research outcomes.
Why Cerevel Therapeutics Chose Dotmatics to Power Their Neuroscience Research
Cerevel Therapeutics, aiming to advance neuroscience research with support from Pfizer and Bain Capital, selected Dotmatics for its comprehensive, scalable cloud-based lab software platform that integrates electronic lab notebooks, assay automation, sample and inventory management, instrument integration, and advanced data analytics, enabling secure, collaborative, and efficient R&D workflows across biology and chemistry labs.
About Dotmatics
Dotmatics is a science-driven company with a mission to build the world’s most powerful scientific R&D platform by uniting best-in-class software applications into a flexible, data-driven ecosystem used by over 2 million scientists worldwide, enabling collaboration, automation, and analysis to accelerate innovation and address global challenges in health, environment, and safety.
What's New in Dotmatics Platform Version 6.1
Dotmatics Platform version 6.1 introduces a redesigned Inventory Module with enhanced hierarchies and workflows, modernized ELN form building with self-signing features, improved data discovery including multi-step reaction querying and large dataset exports, richer workspace visualizations, and expanded integrations supporting FAIR data principles and bidirectional biological sequence exchanges with tools like Geneious Prime, SnapGene, and Geneious Biologics.
Dotmatics Supports Umicore Corporate R&D in Processing of Experimental Data
Dotmatics has been chosen by Umicore Corporate R&D to implement its R&D innovation platform, including an electronic laboratory notebook for over 200 users, to digitalize and standardize data processing across Umicore’s Catalysis, Energy & Surface Technologies, and Recycling divisions, thereby enabling researchers to efficiently generate data-driven insights and accelerate innovation in materials science, chemistry, and metallurgy over the next five years.